-
GlaxoSmithKline, CureVac In Pact To Develop Vaccines For COVID-19 Variants
Wednesday, February 3, 2021 - 6:13am | 390Read More...U.K.-based GlaxoSmithKline Plc (NYSE: GSK) and Germany’s CureVac BV (NASDAQ: CVAC) have announced to work together in a €150 million collaboration for the development of a new generation of COVID-19 vaccines to tackle emerging variants of the...
-
Fintech Focus For January 4, 2021
Sunday, January 3, 2021 - 12:58pm | 1446Read More...Quote To Start The Day: Cheers to a new year and another chance for us to get it right. Source: Oprah Winfrey One Big Thing In Fintech: The banking industry has not been spared from the impact of Covid-19. Bank of America, for one, saw profits drop 16% year-over-year (YoY) in Q3’20 to $4.9B...
-
Maravai IPO: What Investors Should Know About Pfizer/BioNTech COVID-19 Vaccine Partner
Thursday, November 19, 2020 - 5:51pm | 357Read More...Maravai Life Sciences Holdings (NASDAQ:MRVI) will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on selling 50 million shares at a price point of $24 to $27. About Maravai: The company has over 5000...
